Cargando…
Response to letter titled ‘Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?’
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788196/ https://www.ncbi.nlm.nih.gov/pubmed/32229545 http://dx.doi.org/10.1136/gutjnl-2020-321170 |
| _version_ | 1783632982577250304 |
|---|---|
| author | Bergman, JJGHM |
| author_facet | Bergman, JJGHM |
| author_sort | Bergman, JJGHM |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7788196 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77881962021-01-14 Response to letter titled ‘Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?’ Bergman, JJGHM Gut PostScript BMJ Publishing Group 2021-01 2020-03-30 /pmc/articles/PMC7788196/ /pubmed/32229545 http://dx.doi.org/10.1136/gutjnl-2020-321170 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | PostScript Bergman, JJGHM Response to letter titled ‘Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?’ |
| title | Response to letter titled ‘Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?’ |
| title_full | Response to letter titled ‘Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?’ |
| title_fullStr | Response to letter titled ‘Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?’ |
| title_full_unstemmed | Response to letter titled ‘Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?’ |
| title_short | Response to letter titled ‘Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?’ |
| title_sort | response to letter titled ‘reduction of hba1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?’ |
| topic | PostScript |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788196/ https://www.ncbi.nlm.nih.gov/pubmed/32229545 http://dx.doi.org/10.1136/gutjnl-2020-321170 |
| work_keys_str_mv | AT bergmanjjghm responsetolettertitledreductionofhba1cinpatientswithtype2diabetesfollowingduodenalmucosalresurfacingcouldotherfactorsbeatplay |